Mar 25 |
Sanara MedTech reports Q4 results
|
Mar 25 |
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results
|
Mar 25 |
Earnings Scheduled For March 25, 2024
|
Mar 13 |
Investors in Sanara MedTech (NASDAQ:SMTI) have seen fantastic returns of 541% over the past five years
|
Mar 13 |
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Dates
|
Feb 22 |
Sanara Medtech reports 15.5% rise in prelim Q4 rev
|
Feb 22 |
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023
|
Jan 5 |
Sanara MedTech Inc. (NASDAQ:SMTI) About To Shift From Loss To Profit
|
Dec 4 |
Sanara MedTech Inc.'s (NASDAQ:SMTI) top owners are retail investors with 32% stake, while 31% is held by insiders
|
Nov 30 |
Sanara MedTech Inc. Announces the Publication of a 5,335 Patient Study Demonstrating a Significant Reduction in Surgical Site Infections When Activated Collagen (CellerateRX® Surgical Powder) Was Used to Promote Wound Healing
|